Top Page
Aquirian Limited
(Sydney:AQN)
Aquirian Limited (AQN) vs. iShares MSCI Australia ETF (EWA)
Aquirian Limited Business Overview & Revenue Model
Aquirian Limited Financial Statement Overview
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.21M | 23.07M | 26.16M | 17.43M | 12.46M | 10.46M |
| Gross Profit | 4.59M | 13.10M | 15.62M | 9.97M | 2.03M | 1.72M |
| EBITDA | 1.45M | 2.06M | 3.59M | 2.75M | 1.74M | 1.66M |
| Net Income | -1.30M | -649.00K | 546.82K | 558.15K | 623.36K | 1.17M |
Balance Sheet | ||||||
| Total Assets | 32.01M | 33.38M | 25.72M | 22.97M | 8.40M | 4.91M |
| Cash, Cash Equivalents and Short-Term Investments | 3.79M | 4.73M | 3.32M | 7.99M | 1.67M | 1.77M |
| Total Debt | 15.37M | 16.07M | 9.30M | 7.07M | 3.21M | 1.52M |
| Total Liabilities | 21.16M | 22.12M | 13.73M | 11.92M | 5.98M | 3.12M |
| Stockholders Equity | 10.85M | 11.27M | 11.99M | 11.05M | 2.42M | 1.79M |
Cash Flow | ||||||
| Free Cash Flow | 1.71M | 3.06M | -4.98M | -1.33M | 465.41K | 776.07K |
| Operating Cash Flow | 3.56M | 6.79M | 793.75K | 2.10M | 1.25M | 1.12M |
| Investing Cash Flow | -3.41M | -2.27M | -5.65M | -6.07M | -1.19M | 57.85K |
| Financing Cash Flow | -3.74M | -3.12M | 184.28K | 10.28M | -156.35K | -710.31K |
Aquirian Limited Technical Analysis
Aquirian Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$18.99M | 6.91 | 14.71% | ― | -17.71% | ― | |
62 Neutral | AU$9.70M | 11.43 | 9.53% | ― | 11.60% | ― | |
61 Neutral | €20.26M | 33.33 | 5.95% | ― | -10.84% | ― | |
59 Neutral | AU$1.63B | 9.60 | 11.29% | 3.70% | 6.59% | 5.93% | |
56 Neutral | AU$33.49M | ― | -11.18% | ― | -0.46% | -323.61% | |
54 Neutral | AU$40.09M | ― | -35.80% | ― | -32.52% | -300.55% | |
54 Neutral | AU$30.77M | ― | -22.62% | ― | 6.37% | 20.31% |
Aquirian Limited Corporate Events
Aquirian Limited has announced that David Kelly will transition from Executive Director of Operations to a Non-Executive Director role, effective July 1, 2025. Despite stepping back from daily operations, Kelly will continue to provide strategic oversight, particularly for Western Energetics, a subsidiary focused on emulsion manufacturing and field operations. His shift reflects a continued alignment with shareholder interests and commitment to the company’s growth. The transition is seen as a strategic move to leverage Kelly’s expertise in supporting the company’s expansion and operational efficiency, especially in the energetics field services.
Aquirian Limited announced a $5.0 million share placement to fund upgrades at its Wubin emulsion facility and accelerate technology commercialization. The company secured a 12-month tolling agreement expected to generate $1.5 million in revenue and is actively pursuing additional opportunities. The manual Collar Keeper® System is now compatible with more drilling platforms, and the automated version is nearing production trials. These advancements are expected to enhance operational safety and cost-effectiveness, reinforcing Aquirian’s leadership in the industry.
Aquirian Limited presented at the Euroz Hartleys Industrial & Resources Forum, emphasizing its commitment to accelerating innovation and growth. The presentation, while providing a general overview of the company, is not intended as investment advice or an offer of securities. It highlights the inherent risks in securities and advises potential investors to seek professional advice before making investment decisions. The release also notes that forward-looking statements are subject to uncertainties and should not be heavily relied upon.
Aquirian Limited has announced the issuance of unquoted equity securities in the form of unlisted options. The company is issuing 500,000 unlisted options at $0.35 each, expiring on February 27, 2027, and another 500,000 unlisted options at $0.45 each, expiring on February 27, 2028. This move may impact the company’s financial strategy and provide potential benefits to stakeholders by offering new investment opportunities.
Aquirian Limited has announced a change in the director’s interest notice, specifically concerning David Kelly. The change involves the acquisition of 76,923 ordinary shares through a share placement approved by shareholders, increasing Kelly’s indirect holdings to 1,060,474 shares. This move reflects a strategic adjustment in the company’s leadership interests, potentially impacting stakeholder perceptions and the company’s market positioning.
Aquirian Limited has announced a change in the director’s interest, specifically regarding Gregory Patching’s holdings. The update involves the acquisition of 76,923 ordinary shares valued at $19,999.98, which were issued through a share placement approved by shareholders. This change reflects a strategic move to adjust the director’s stake in the company, potentially impacting the company’s governance and shareholder dynamics.
Aquirian Limited announced a change in the director’s interest, with Mr. Adrian Mason acquiring 500,000 ordinary shares and 1,000,000 options through a shareholder-approved share placement. This change reflects a significant increase in Mr. Mason’s stake in the company, potentially indicating confidence in the company’s future prospects and aligning the director’s interests with those of the shareholders.
Aquirian Limited announced a change in the director’s interest, specifically for Mr. Bruce McFadzean, who increased his indirect holdings in the company by acquiring 76,923 ordinary shares through a share placement. This change, approved by shareholders at a General Meeting, reflects a strategic move to enhance Mr. McFadzean’s stake in the company, potentially signaling confidence in the company’s future prospects and aligning his interests more closely with those of other shareholders.
Aquirian Limited announced a change in the director’s interest, with Ms. Alexandra Atkins acquiring 38,462 ordinary shares through a share placement approved by shareholders. This acquisition reflects a strategic move by the company to align its leadership interests with shareholder interests, potentially impacting its market positioning and stakeholder confidence.
Aquirian Limited announced the quotation of 769,231 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of June 6, 2025. This move is part of a previously announced transaction, indicating a strategic step in the company’s financial operations. The issuance of these securities could potentially enhance Aquirian Limited’s market presence and provide additional capital for its business activities, impacting its stakeholders positively.
Aquirian Limited has announced a General Meeting scheduled for May 22, 2025, to be held at their Perth office. Shareholders are encouraged to submit their votes in advance to ensure efficient meeting conduct, with proxy voting details provided. The meeting will cover important business matters, and shareholders are advised to consult professional advisers if unsure about voting.
Aquirian Limited has scheduled a General Meeting on May 22, 2025, to discuss key resolutions. The agenda includes the election of Mr. Adrian Mason as a Director and the ratification of prior issues of March Placement Shares under Listing Rules 7.1 and 7.1A. These resolutions are significant for the company’s governance and capital structure, potentially impacting shareholder value and market perception.